Jevtana

Product manufactured by Sanofi-Aventis U.s. Llc

Application Nr Approved Date Route Status External Links
NDA201023 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Jevtana ® Is Indicated In Combination With Prednisone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With A Docetaxel-Containing Treatment Regimen. Jevtana Is A Microtubule Inhibitor Indicated In Combination With Prednisone For Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With A Docetaxel-Containing Treatment Regimen. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Cabazitaxel CABAZITAXEL ZINC85536932

Comments